Sciatica Market Size (2024 - 2029)

Sciatica Market Analysis

The Sciatica Market is expected to register a CAGR of 9.5% during the forecast period.

Certain factors driving market growth include the high recurrence rate of sciatica in patients, which impacts the market positively as patients try new interventions. Sciatica is likely to recur if the spinal disc that contributed to sciatica is severely damaged. The more damaged the disc, the more likely it is to re-herniate and cause sciatica again.

For instance, in a study published in the National Library of Medicine in August 2022, patients with chronic pain (more than six months) had a poorer outcome following surgery than patients with acute pain (less than six months). Some studies reported a cure rate of more than 75%, but other studies reported cure rates of less than 50%. There are several newer orthopedic procedures to manage sciatica, and these procedures have success rates of 70% and above in the short term. Therefore, with the advances in orthopedic procedures, the market studied is expected to grow over the coming years.

Several environmental and inherent factors thought to influence the development of sciatica have been studied, including gender, body habitus, parity, age, genetic factors, occupation, and environmental factors. For instance, according to Complete Orthopedics in July 2023, sciatica, identified as low back pain with leg pain extending below the knee, impacted 9.9% to 25% of the general population annually in the United States. Thus, the high annual prevalence rates for sciatica in developed nations are increasing demand for its treatment, thereby contributing to market growth.

However, the lack of proper diagnostic tests and the availability of off-label medication are projected to restrain market growth over the forecast period.

Sciatica Industry Segmentation

As per the scope of this report, sciatica refers to pain that radiates along the path of the sciatic nerve, which branches from the lower back through the hips and buttocks and down each leg. Typically, sciatica affects only one side of the body.

The sciatica market is segmented by type, pharmacological therapies, and geography. By type, the market is segmented into acute sciatica, chronic sciatica, and other types. By pharmacological therapies, the market is segmented into non-steroidal anti-inflammatory drugs (NSAIDs), steroids, antidepressants, painkillers, and other pharmacological therapies. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the market size in value terms (USD) for all the abovementioned segments.